Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2026-05-25 @ 6:05 AM
Study NCT ID:
NCT00075894
Status:
COMPLETED
Last Update Posted:
2009-01-13
First Post:
2004-01-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Alanosine in Treating Patients With Progressive or Recurrent Malignant Gliomas
Sponsor:
National Cancer Institute (NCI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
CDR0000349473
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None